Tag Archives: investing

JPM 2026: Partnering, Event/Reception Space Available at RESI JPM

29 Jul

Host your event. Launch your brand. Meet your partners.

By Sougato Das, President and COO, LSN

Sougato-Das

Life Science Nation (LSN) has secured a 20,000 square foot (1900 square meters) space at the Marriott Marquis in Union Square in the heart of JPM Week 2026. This premium venue will serve as the headquarters for the Redefining Every Stage of Investment (RESI) conference on Monday and Tuesday, January 12 and 13—but we’re opening the doors Sunday, January 11 for groups looking to host their own event in the center of the action.

We’re inviting economic development agencies, global trade organizations, venture groups, and industry associations to partner with LSN or book standalone time in this flagship location.

The Space

  • 20,000 square feet of meeting and activation space
  • 4 fully equipped conference rooms (2400 square feet/220 square meters), good for theater-style seating for presentations or a small networking event
  • 90+ RESI-style partnering tables
  • Full-service meeting logistics support available

This space is ideal for:

  • Networking receptions, investor briefings, and pitch showcases
  • Country or region-specific innovation days
  • Workshops, roundtables, or startup presentations
  • Private investor or industry partner meetings

Flexible Integration Options

  • January 11 (Sunday): Available for standalone programs, private events, or pre-RESI activities
  • January 12 and 13 (Monday and Tuesday): Integrate into the RESI JPM program, gain access to hundreds of global investors, and use the space to host partner meetings or specialized tracks within the RESI ecosystem

LSN is already in discussion with a range of organizations, including tech hubs, economic development agencies, service providers, and nonprofit patient groups who are seeking affordable options for hosting events and partnering at JPM.

Why Co-Locate with LSN During JPM?

  • Prime Union Square location just steps from the major hotel hubs and investor meetings
  • Built-in foot traffic and visibility from RESI attendees, investors, and partners
  • Flexible use of infrastructure and logistics support from the LSN team
  • Branding and signage opportunities throughout the venue
  • Streamlined meeting scheduling and visibility if integrated into the RESI partnering platform

Make It Yours

Whether you’re looking to host a private country reception, a thematic track inside RESI, or a custom event that aligns with your mission, the space is move-in ready and centrally located. We can help with meeting set-up, agenda development, signage, staffing, registration flow, and more.

Interested in booking or learning more?
Contact salescore@lifesciencenation.com to discuss options, availability, and pricing.

Let’s create a high-impact presence for your organization at the most important week in global life sciences.

Tags: , , , , , , , , , ,

Hot Investor Mandate: VC Firm Headquartered in Asia Makes Early- to Expansion-Stage Investments Into Digital Healthcare Companies With Asia Market Potential 

29 Jul

A venture capital investor based in Asia with a presence in the US makes early- to expansion-stage investments across multiple sectors, ranging from smart cities and fintech to healthcare. Investment size is highly variable depending on the company’s stage. The firm invests alongside other venture capital firms in companies located in North America and Europe that have a market expansion strategy into Asia. 

The firm takes an opportunistic approach to digital healthcare companies, particularly those leveraging AI and bioinformatics to accelerate the drug discovery process. 

The firm seeks entrepreneurs who are passionate, driven, and enthusiastic, with sustainable business models and globally scalable ideas. 

If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com. 

Tags: , , , ,

Hot Investor Mandate: Venture Arm of Investment Bank Seek Therapeutics and Medtech Companies in CNS, Oncology, and More, Focusing on US Based Opportunities

29 Jul

An investment bank headquartered in the US  does not act as a traditional investment bank, as the firm participates in venture capital, investing in and working with early-stage technology and life science companies with the main goal of taking the companies to public markets. The firm has also spun out and out-licensed technologies from universities and has capabilities to help with company formation, business strategy, IP, and early IPOs. The firm utilizes a sister company to further analyze company technologies and IPs. The firm can fund from $5-12M USD from Seed to Series A rounds with preference in US-based companies, though the firm is open to global companies. 
 
The firm is looking at biotech, medical devices, and diagnostics companies and is technology-agnostic. The firm generally does not look at digital health. There has been strong interest in immuno-oncology, neurology, and CNS. 
 

The firm works closely with companies and founders and will lead investment rounds. The firm typically requires taking a board or observer seat while deciding strategy, and once the company goes public, the firm will bring in a board member with expertise in the field. 

If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com. 

Tags: , , , ,

Hot Investor Mandate: VC Firm Focuses on Global Early-Stage Medical Device Investments, With Strong Interest in Companies Developing Class III Devices

29 Jul

A venture capital firm, founded in 2019, is a global venture capital investor. The firm specializes in early-stage medical device companies and actively leverages expertise and industry resources to support portfolio companies. The firm prefers taking a leading role in investment rounds and may seek board seats in such cases. 

The firm focuses on medical devices and is open to all subsectors and indications. The firm seeks innovative technologies, primarily investing in Class III devices, and occasionally considers Class II devices if they demonstrate significant innovation. The firm is open to working with companies at all stages, including those in the early idea phase. 

The firm prefers founding teams with strong scientific expertise and comprehensive knowledge of their respective fields. 

If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com. 

Tags: , , , ,

Hot Investor Mandate: USA-Based Early-Stage Venture Fund Invests in Seed Stage Companies With Opportunistic Interests Across Life Sciences

29 Jul

An early-stage venture capital firm, headquartered in the U.S., allocates roughly 40% of its investments to life sciences. The firm primarily invests from the Seed stage, with the ability to provide follow-on capital. Check sizes are flexible, typically reaching up to mid-6 figures. The firm is open to evaluating opportunities from global companies. 

The firm has broad interests in life sciences and healthcare sectors and considers all types of innovative technologies and indication/disease areas.  
 
The firm does not impose specific requirements on company structure or management teams. 

If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com. 

Tags: , , , ,

Hot Investor Mandate: Investing Holding Company Backed by Leading European Institutions Seeks Europe and US-Based Companies in All Life Science Sectors 

22 Jul

An investment holding company founded by leading European institutions has raised over €100 million from a base of more than 200 institutional and private shareholders. The firm invests from Seed to Series B stages, with a strong preference for early-stage companies and potential for follow-on funding. Check sizes can reach up to $2 million per company, with flexibility based on the stage of development. The firm is open to both leading and co-investing, and while it is primarily Europe-focused, it is increasingly pursuing U.S. opportunities. 

The firm invests across biotech, MedTech (including therapeutics, medical devices, and diagnostics), and digital health. It remains modality- and indication-agnostic, seeking opportunities with strong growth potential and technological innovation. 

There are no specific requirements for company founding teams, and the firm works closely with its portfolio companies to support their development. 

If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com. 

Tags: , , , ,

Hot Investor Mandate: Global Manufacturing Company Seeks Strategic Partnerships With Early-Stage Medical Device and Digital Health Companies Across the Globe  

22 Jul

A global manufacturing company, with over a century of history, is a leader in advanced materials and pressure-sensitive adhesive technologies. With a strong presence in the U.S. for many decades, it has built a reputation for innovation across industries including aerospace, electronics, healthcare, automotive, housing/construction, environmental applications, and general industry. 

In healthcare, the firm is actively seeking strategic partnerships with early-stage companies that complement its product lines. While it is open to meeting startups at the Series A stage, its focus is more on the development stage of technologies rather than funding rounds. The company has a global outlook and welcomes partnerships worldwide. 
 
The company is particularly interested in medical devices and digital health solutions. Priority technologies include sensors for applications such as injury prevention, rehabilitation for musculoskeletal disorders, stroke recovery, and neurological conditions. The company favors startups with prototypes and looks for technologies aligned with its existing products, such as flexible or stress sensors. 

If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com. 

Tags: , , , ,

← Older Entries
Newer Entries →